
News|Articles|November 11, 2025
An Analysis of solid tumor oncology patients’ respiratory vaccination rates in accordance with the 2024 American Society of Clinical Oncology (ASCO) guidelines
Author(s)Sponsored by Pfizer
Key Takeaways
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Trending on Managed Healthcare Executive
1
IV iron treatment improves survival, increases hemoglobin levels in anemic patients with acute bacterial infection | ASH 2025
2
Gene therapy in the real world: High priced, a long process and still relatively few patients | ASH 2025
3
Jaypirca shows promise as a frontline treatment for CLL/SLL patients | ASH 2025
4
Venclexta combination improves survival and lowers hospital stays for AML patients | ASH 2025
5




















































